These results are consistent with the previous reports that progesterone receptor associates with ERα and modulates ERα action in breast cancer [31], and FOXA1 is the pioneer factor for shaping the genome-wide distribution of ERα [36], respectively. Here, FOXA1 is linked to breast carcinoma.